{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T00:04:07Z","timestamp":1789603447180,"version":"build-2803163510"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,28]],"date-time":"2026-06-28T00:00:00Z","timestamp":1782604800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T00:00:00Z","timestamp":1789603200000},"content-version":"vor","delay-in-days":81,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Amino Acids"],"DOI":"10.1007\/s00726-026-03540-2","type":"journal-article","created":{"date-parts":[[2026,6,28]],"date-time":"2026-06-28T19:44:49Z","timestamp":1782675889000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Reprogramming parasitic signatures into anticancer peptide candidates: in silico discovery of Leishmania major-derived peptides"],"prefix":"10.1007","volume":"58","author":[{"given":"Abbas","family":"Dehghanian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Izadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahra","family":"Minaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mostafa","family":"Cheshrokh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh","family":"Fathi Tadavani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anahita","family":"Masoudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Aref","family":"Bagherzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7001-7842","authenticated-orcid":false,"given":"Mirza Ali","family":"Mofazzal Jahromi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0046-4772","authenticated-orcid":false,"given":"Majid","family":"Pirestani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,28]]},"reference":[{"key":"3540_CR1","unstructured":"Abbas AK, Lichtman AH, Pillai S (2014) Cellular and molecular immunology E-book. Elsevier Health Sciences"},{"key":"3540_CR2","doi-asserted-by":"publisher","DOI":"10.1007\/978-94-007-6726-3","author":"CM Adade","year":"2015","unstructured":"Adade CM, Souto-Padr\u00f3n T (2015) Venoms as sources of novel anti-parasitic agents. Toxins Drug Discov. https:\/\/doi.org\/10.1007\/978-94-007-6726-3","journal-title":"Toxins Drug Discov"},{"key":"3540_CR3","doi-asserted-by":"publisher","DOI":"10.3389\/fchem.2021.688446","author":"S Afonin","year":"2021","unstructured":"Afonin S et al (2021) In vivo behavior of the antibacterial peptide cyclo [RRRWFW], explored using a 3-hydroxychromone-derived fluorescent amino acid. Front Chem. https:\/\/doi.org\/10.3389\/fchem.2021.688446","journal-title":"Front Chem"},{"key":"3540_CR4","doi-asserted-by":"publisher","DOI":"10.1093\/bib\/bbaa153","author":"P Agrawal","year":"2021","unstructured":"Agrawal P et al (2021) AntiCP 2.0: an updated model for predicting anticancer peptides. Brief Bioinform. https:\/\/doi.org\/10.1093\/bib\/bbaa153","journal-title":"Brief Bioinform"},{"key":"3540_CR5","doi-asserted-by":"crossref","unstructured":"Barati N et al (2022) Anticancer activity of antigen B from hydatid cyst fluid of Echinococcus granulosus on melanoma cancer cell line. Chemo Open Access 11:181","DOI":"10.21203\/rs.3.rs-1655273\/v1"},{"issue":"22","key":"3540_CR6","doi-asserted-by":"publisher","first-page":"32383","DOI":"10.1007\/s11356-021-17090-5","volume":"29","author":"A Asghari","year":"2022","unstructured":"Asghari A et al (2022) Promising effects of parasite-derived compounds on tumor regression: a systematic review of in vitro and in vivo studies. Environ Sci Pollut Res 29(22):32383\u201332396. https:\/\/doi.org\/10.1007\/s11356-021-17090-5","journal-title":"Environ Sci Pollut Res"},{"issue":"1","key":"3540_CR7","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-18152-5","volume":"12","author":"MA Bagherzadeh","year":"2022","unstructured":"Bagherzadeh MA et al (2022) Considering epitopes conservity in targeting SARS-CoV-2 mutations in variants: a novel immunoinformatics approach to vaccine design. Sci Rep 12(1):14017","journal-title":"Sci Rep"},{"key":"3540_CR8","doi-asserted-by":"publisher","unstructured":"Bagherzadeh MA et al (2026) Development of anticancer peptides-based Echinococcus granulosus by in silico approaches. Discov Appl Sci. https:\/\/doi.org\/10.1007\/s42452-026-08515-2B","DOI":"10.1007\/s42452-026-08515-2B"},{"issue":"8","key":"3540_CR9","doi-asserted-by":"publisher","DOI":"10.3390\/biom11081120","volume":"11","author":"OO Bakare","year":"2021","unstructured":"Bakare OO et al (2021) Biomedical relevance of novel anticancer peptides in the sensitive treatment of cancer. Biomolecules 11(8):1120. https:\/\/doi.org\/10.3390\/biom11081120","journal-title":"Biomolecules"},{"key":"3540_CR10","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/230176","author":"E Berriel","year":"2013","unstructured":"Berriel E et al (2013) Antitumor activity of human hydatid cyst fluid in a murine model of colon cancer. Sci World J 2013(1):230176. https:\/\/doi.org\/10.1155\/2013\/230176","journal-title":"Sci World J"},{"key":"3540_CR42","doi-asserted-by":"publisher","unstructured":"Bray F et al (2024) Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer J Clin 74(3):229-63.   https:\/\/doi.org\/10.3322\/caac.21834","DOI":"10.3322\/caac.21834"},{"issue":"6","key":"3540_CR11","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1007\/s12282-020-01112-0","volume":"27","author":"A Caner","year":"2020","unstructured":"Caner A et al (2020) Targeting of antitumor \u0131mmune responses with live-attenuated Leishmania strains in breast cancer model. Breast Cancer (Tokyo) 27(6):1082\u20131095. https:\/\/doi.org\/10.1007\/s12282-020-01112-0","journal-title":"Breast Cancer (Tokyo)"},{"key":"3540_CR12","doi-asserted-by":"publisher","DOI":"10.2147\/IJN.S343902","author":"B Chen","year":"2022","unstructured":"Chen B et al (2022) iRGD tumor-penetrating peptide-modified nano-delivery system based on a marine sulfated polysaccharide for enhanced anti-tumor efficiency against breast cancer. Int J Nanomed. https:\/\/doi.org\/10.2147\/IJN.S343902","journal-title":"Int J Nanomed"},{"key":"3540_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.114996","volume":"164","author":"RK Chinnadurai","year":"2023","unstructured":"Chinnadurai RK et al (2023) Current research status of anti-cancer peptides: mechanism of action, production, and clinical applications. Biomed Pharm 164:114996. https:\/\/doi.org\/10.1016\/j.biopha.2023.114996","journal-title":"Biomed Pharm"},{"issue":"1","key":"3540_CR14","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines12010201","volume":"12","author":"P Chunarkar-Patil","year":"2024","unstructured":"Chunarkar-Patil P et al (2024) Anticancer drug discovery based on natural products: from computational approaches to clinical studies. Biomedicines 12(1):201. https:\/\/doi.org\/10.3390\/biomedicines12010201","journal-title":"Biomedicines"},{"key":"3540_CR15","doi-asserted-by":"publisher","DOI":"10.4103\/2277-9175.175242","author":"S Daneshpour","year":"2016","unstructured":"Daneshpour S et al (2016) Common antigens between hydatid cyst and cancers. AAdv Biomed Res. https:\/\/doi.org\/10.4103\/2277-9175.175242","journal-title":"Adv Biomed Res"},{"key":"3540_CR16","doi-asserted-by":"publisher","DOI":"10.4103\/abr.abr_220_18","author":"S Daneshpour","year":"2019","unstructured":"Daneshpour S et al (2019) Effect of hydatid cyst fluid antigens on induction of apoptosis on breast cancer cells. Adv Biomed Res. https:\/\/doi.org\/10.4103\/abr.abr_220_18","journal-title":"Adv Biomed Res"},{"key":"3540_CR17","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2015.00524","volume":"6","author":"SCF De Mendonca","year":"2015","unstructured":"De Mendonca SCF, Cysne-Finkelstein L, Matos D (2015) Kinetoplastid membrane protein-11 as a vaccine candidate and a virulence factor in Leishmania. Front Immunol 6:524. https:\/\/doi.org\/10.3389\/fimmu.2015.00524","journal-title":"Front Immunol"},{"issue":"3","key":"3540_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2024.113932","volume":"43","author":"JC Dos Santos","year":"2024","unstructured":"Dos Santos JC et al (2024) Leishmania braziliensis enhances monocyte responses to promote anti-tumor activity. Cell Rep 43(3):113932. https:\/\/doi.org\/10.1016\/j.celrep.2024.113932","journal-title":"Cell Rep"},{"issue":"1","key":"3540_CR19","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1186\/s40001-024-02057-2","volume":"29","author":"MM Eissa","year":"2024","unstructured":"Eissa MM, Salem AE, El Skhawy N (2024) Parasites revive hope for cancer therapy. Eur J Med Res 29(1):489. https:\/\/doi.org\/10.1186\/s40001-024-02057-2","journal-title":"Eur J Med Res"},{"issue":"3","key":"3540_CR20","first-page":"309","volume":"47","author":"B Farhood","year":"2018","unstructured":"Farhood B, Geraily G, Alizadeh A (2018) Incidence and mortality of various cancers in Iran and compare to other countries: a review article. Iran J public health 47(3):309","journal-title":"Iran J public health"},{"issue":"5","key":"3540_CR21","first-page":"327","volume":"14","author":"L Foulds","year":"1954","unstructured":"Foulds L (1954) The experimental study of tumor progression: a review. Cancer Res 14(5):327\u2013339","journal-title":"Cancer Res"},{"issue":"9","key":"3540_CR22","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics13091433","volume":"13","author":"I Gaurav","year":"2021","unstructured":"Gaurav I et al (2021) Peptide-conjugated nano delivery systems for therapy and diagnosis of cancer. Pharmaceutics 13(9):1433. https:\/\/doi.org\/10.3390\/pharmaceutics13091433","journal-title":"Pharmaceutics"},{"issue":"11","key":"3540_CR23","doi-asserted-by":"publisher","first-page":"6893","DOI":"10.1074\/jbc.M805861200","volume":"284","author":"M Hall\u00e9","year":"2009","unstructured":"Hall\u00e9 M et al (2009) The leishmania surface protease gp63 cleaves multiple intracellular proteins and actively participates in p38 Mitogen-activated protein kinase inactivation. J Biol Chem 284(11):6893\u20136908. https:\/\/doi.org\/10.1074\/jbc.M805861200","journal-title":"J Biol Chem"},{"key":"3540_CR24","doi-asserted-by":"publisher","unstructured":"Hilchie A, Hoskin D, Power Coombs M (2019) Anticancer activities of natural and synthetic peptides. In: Antimicrobial peptides: basics for clinical application. Springer, Singapore, pp 131\u2013147. https:\/\/doi.org\/10.1007\/978-981-13-3588-4_9","DOI":"10.1007\/978-981-13-3588-4_9"},{"issue":"3","key":"3540_CR25","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19030919","volume":"19","author":"HK Kang","year":"2018","unstructured":"Kang HK et al (2018) Therapeutic properties and biological benefits of marine-derived anticancer peptides. International journal of molecular sciences 19(3):919. https:\/\/doi.org\/10.3390\/ijms19030919","journal-title":"International journal of molecular sciences"},{"issue":"1","key":"3540_CR26","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s11658-022-00332-w","volume":"27","author":"M Karami Fath","year":"2022","unstructured":"Karami Fath M et al (2022) Anti-cancer peptide-based therapeutic strategies in solid tumors. Cell Mol Biol Lett 27(1):33. https:\/\/doi.org\/10.1186\/s11658-022-00332-w","journal-title":"Cell Mol Biol Lett"},{"issue":"1","key":"3540_CR27","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1080\/02648725.2022.2082157","volume":"39","author":"A Lath","year":"2023","unstructured":"Lath A et al (2023) Anti-cancer peptides: their current trends in the development of peptide-based therapy and anti-tumor drugs. Biotechnol Genetic Eng Rev 39(1):45\u201384. https:\/\/doi.org\/10.1080\/02648725.2022.2082157","journal-title":"Biotechnol Genetic Eng Rev"},{"issue":"18","key":"3540_CR28","doi-asserted-by":"publisher","DOI":"10.3390\/molecules25184245","volume":"25","author":"Y Liscano","year":"2020","unstructured":"Liscano Y, O\u00f1ate-Garz\u00f3n J, Delgado JP (2020) Peptides with dual antimicrobial\u2013anticancer activity: strategies to overcome peptide limitations and rational design of anticancer peptides. Molecules 25(18):4245. https:\/\/doi.org\/10.3390\/molecules25184245","journal-title":"Molecules"},{"issue":"2","key":"3540_CR29","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/0167-4838(95)00155-5","volume":"1253","author":"MH Macdonald","year":"1995","unstructured":"Macdonald MH, Morrison CJ, McMaster WR (1995) Analysis of the active site and activation mechanism of the Leishmania surface metalloproteinase GP63. Biochimica et Biophysica Acta (BBA)-Protein Struct Mol Enzymol 1253(2):199\u2013207. https:\/\/doi.org\/10.1016\/0167-4838(95)00155-5","journal-title":"Biochimica et Biophysica Acta (BBA)-Protein Struct Mol Enzymol"},{"key":"3540_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbi.2022.110194","volume":"368","author":"P Norouzi","year":"2022","unstructured":"Norouzi P, Mirmohammadi M, Tehrani MHH (2022) Anticancer peptides mechanisms, simple and complex. Chemico-Biol Interact 368:110194. https:\/\/doi.org\/10.1016\/j.cbi.2022.110194","journal-title":"Chemico-Biol Interact"},{"issue":"3","key":"3540_CR31","doi-asserted-by":"publisher","first-page":"775","DOI":"10.3892\/ijo.2013.2000","volume":"43","author":"V Noya","year":"2013","unstructured":"Noya V et al (2013) Mucin-like peptides from Echinococcus granulosus induce antitumor activity. Int J Oncol 43(3):775\u2013784. https:\/\/doi.org\/10.3892\/ijo.2013.2000","journal-title":"Int J Oncol"},{"key":"3540_CR32","doi-asserted-by":"publisher","first-page":"105266","DOI":"10.1016\/j.bioorg.2021.105266","volume":"115","author":"H Okasha","year":"2021","unstructured":"Okasha H, Samir S, Nasr SM (2021) Purified recombinant human Chromogranin A N46 peptide with remarkable anticancer effect on human colon cancer cells. Bioorg Chem 115:105266. https:\/\/doi.org\/10.1016\/j.bioorg.2021.105266","journal-title":"Bioorg Chem"},{"issue":"5","key":"3540_CR33","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1080\/07352689.2013.773238","volume":"32","author":"S Prabhu","year":"2013","unstructured":"Prabhu S et al (2013) Anionic antimicrobial and anticancer peptides from plants. Critic Rev Plant Sci 32(5):303\u2013320. https:\/\/doi.org\/10.1080\/07352689.2013.773238","journal-title":"Critic Rev Plant Sci"},{"key":"3540_CR34","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2022.882608","volume":"12","author":"P Ruenchit","year":"2022","unstructured":"Ruenchit P et al (2022) Peptide of Trichinella spiralis infective larval extract that harnesses growth of human hepatoma cells. Front Cell Infect Microbiol 12:882608. https:\/\/doi.org\/10.3389\/fcimb.2022.882608","journal-title":"Front Cell Infect Microbiol"},{"key":"3540_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2021.107955","volume":"99","author":"M Shakibapour","year":"2021","unstructured":"Shakibapour M et al (2021) Anti-cancer immunoprotective effects of immunization with hydatid cyst wall antigens in a non-immunogenic and metastatic triple-negative murine mammary carcinoma model. Int Immunopharmacol 99:107955. https:\/\/doi.org\/10.1016\/j.intimp.2021.107955","journal-title":"Int Immunopharmacol"},{"key":"3540_CR36","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21820","author":"RL Siegel","year":"2024","unstructured":"Siegel RL, Giaquinto AN, Jemal A (2024) Cancer statistics, 2024. CA: A Cancer J Clin. https:\/\/doi.org\/10.3322\/caac.21820","journal-title":"CA: A Cancer J Clin"},{"issue":"6","key":"3540_CR37","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1038\/s41388-019-1056-3","volume":"39","author":"A Sorolla","year":"2020","unstructured":"Sorolla A et al (2020) Precision medicine by designer interference peptides: applications in oncology and molecular therapeutics. Oncogene 39(6):1167\u20131184. https:\/\/doi.org\/10.1038\/s41388-019-1056-3","journal-title":"Oncogene"},{"issue":"3","key":"3540_CR38","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H et al (2021) Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Cancer J Clin 71(3):209\u2013249. https:\/\/doi.org\/10.3322\/caac.21660","journal-title":"Cancer J Clin"},{"issue":"12","key":"3540_CR39","doi-asserted-by":"publisher","first-page":"2850","DOI":"10.3390\/molecules25122850","volume":"25","author":"AL Tornesello","year":"2020","unstructured":"Tornesello AL et al (2020) Antimicrobial peptides as anticancer agents: functional properties and biological activities. Molecules 25(12):2850. https:\/\/doi.org\/10.3390\/molecules25122850","journal-title":"Molecules"},{"key":"3540_CR40","doi-asserted-by":"publisher","DOI":"10.1038\/srep02984","volume":"3","author":"A Tyagi","year":"2013","unstructured":"Tyagi A et al (2013) In silico models for designing and discovering novel anticancer peptides. Sci Rep 3:2984. https:\/\/doi.org\/10.1038\/srep02984","journal-title":"Sci Rep"},{"issue":"Database issue","key":"3540_CR41","doi-asserted-by":"publisher","first-page":"D837","DOI":"10.1093\/nar\/gku892","volume":"43","author":"A Tyagi","year":"2015","unstructured":"Tyagi A et al (2015) CancerPPD: a database of anticancer peptides and proteins. Nucleic Acids Res 43(Database issue):D837-43. https:\/\/doi.org\/10.1093\/nar\/gku892","journal-title":"Nucleic Acids Res"},{"issue":"10","key":"3540_CR43","doi-asserted-by":"publisher","first-page":"8027","DOI":"10.1007\/s00432-023-04694-2","volume":"149","author":"M Yousefi","year":"2023","unstructured":"Yousefi M et al (2023) Parasites as potential targets for cancer immunotherapy. J Cancer Res Clinic Oncol 149(10):8027\u20138038. https:\/\/doi.org\/10.1007\/s00432-023-04694-2","journal-title":"J Cancer Res Clinic Oncol"},{"key":"3540_CR44","doi-asserted-by":"publisher","first-page":"1463088","DOI":"10.3389\/fonc.2024.1463088","volume":"14","author":"H Zare-Zardini","year":"2024","unstructured":"Zare-Zardini H et al (2024) From defense to offense: antimicrobial peptides as promising therapeutics for cancer. Front Oncol 14:1463088. https:\/\/doi.org\/10.3389\/fonc.2024.1463088","journal-title":"Front Oncol"},{"issue":"1","key":"3540_CR45","doi-asserted-by":"publisher","first-page":"5","DOI":"10.12336\/biomatertransl.2023.01.003","volume":"4","author":"Y Zhang","year":"2023","unstructured":"Zhang Y et al (2023) Bioactive peptides for anticancer therapies. Biomater Transl 4(1):5. https:\/\/doi.org\/10.12336\/biomatertransl.2023.01.003","journal-title":"Biomater Transl"}],"container-title":["Amino Acids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00726-026-03540-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00726-026-03540-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00726-026-03540-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T23:43:44Z","timestamp":1789602224000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00726-026-03540-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,28]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3540"],"URL":"https:\/\/doi.org\/10.1007\/s00726-026-03540-2","relation":{},"ISSN":["1438-2199"],"issn-type":[{"value":"1438-2199","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,28]]},"assertion":[{"value":"2 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed based on the guidelines of the Medical Ethics Committee of the Jahrom University of Medical Sciences (IR.JUMS.REC.1400.085). The authors declare that ChatGPT version 4.0 (OpenAI, USA) and Grammarly (Grammarly, USA) were used for paraphrasing and editing the final context in accordance with Springer policy.","order":2,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"53"}}